ADHD
253 results
101 - 200
Sleep counseling improves sleep and symptoms in children with ADHD- Screening tool for adult ADHD of uncertain effectiveness
- Guanfacine effective for ADHD but side effects are significant
Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults- Higher risk of psychosis with amphetamines than methylphenidate in treatment of ADHD
- St. John's wort not effective for treatment of ADHD
- 2019 guidelines for ADHD: structure plus medication
- A restriction diet will benefit some children with ADHD
- Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents
Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents - Bupropion for attention deficit hyperactivity disorder (ADHD) in adults
- In-school neurofeedback improves ADHD symptom scores
- Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
- Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
- Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders
- Cognitive‐behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults
- Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents
- No increased risk of ASD, ADHD, or SGA with first-trimester antidepressant use
- Digital media use associated with ADHD symptom development among adolescents
- Immediate‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
- Cognitive‐behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults
- Acupuncture for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents: Cochrane systematic review
- ADHD drugs do not increase serious CV events in children and young adults
- Acetaminophen use during pregnancy is not associated with risk of autism, ADHD, or intellectual disability
- Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents: Cochrane systematic review
- Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults: Cochrane systematic review
- Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years
- Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years: Cochrane systematic review
- Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non‐randomised studies
- Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non-randomised studies: Cochrane systematic review
- Stimulant and non‐stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy
- Risperidone for attention‐deficit hyperactivity disorder in people with intellectual disabilities
- Amfetamine for attention deficit hyperactivity disorder in people with intellectual disabilities
- Maternal triptan use during pregnancy is not associated with risk of attention-deficit/hyperactivity disorder in offspring
- Family therapy for attention‐deficit disorder or attention‐deficit/hyperactivity disorder in children and adolescents
- Learning disorders
- Atomoxetine better than placebo but not uniformly effective in young children
- Prescription stimulant use during pregnancy is unlikely to harm offspring
- No association between stimulant treatment for attention-deficit/hyperactivity disorder and substance use
- Treatments for attention-deficit/hyperactivity disorder
- Psychopharmacotherapy in children and adolescents
- Prenatal cannabis exposure is not associated with an increased incidence of several neuropsychiatric disorders